Management of Upper Gastrointestinal Bleeding Due to NSAID Gastropathy That is Unresponsive to Ranitidine by Erawati, L. (Lusy) et al.
Volume 3, Number 2, August 2003 59
CASE REPORT
Management of Upper Gastrointestinal Bleeding due to
NSAID Gastropathy that is Unresponsive to Ranitidine
Lusy Erawati*, Sayid Ridho*, Ginova Nainggolan*,
Ari F. Syam**, Chudahman Manan**
*Department of Internal Medicine, Faculty of Medicine, University of Indonesian, Cipto Mangunkusumo
General National Hospital, Indonesia
**Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of
Indonesian, Cipto Mangunkusumo General National Hospital, Indonesia
ABSTRACT
Non steroidal anti-inflammatory drugs (NSAIDS) are now commonly used in clinical practice. On the
other hands, this drug could result severe complication such as bleeding and perforation. In such condition,
proton pump inhibitor can be used to stop bleeding than H2 antagonists.
We reported one cases of upper gastrointestinal bleeding due to NSAID gastropathy that was
unresponsive to Ranitidine. The treatment was suitable to proton pump inhibitor that could overcome upper
gastrointestinal bleeding.
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INTRODUCTION
Hematemesis refers to black bloody vomiting from
the upper gastrointestinal tract. Melena refers to black
stool from the upper gastrointestinal tract. The upper
gastrointestinal tract covers the part of the
gastrointestinal tract proximal to the Treitz ligament,
starting from the proximal jejunum, to the duodenum,
gaster, and esophagus.1,2
Upper gastrointestinal tract bleeding or
hematemesis-melena is an emergency in the field of
internal medicine. Its prevalence in the United States
and Europe is approximately 0.1% with a mortality rate
of approximately 10%.3 The mortality rate at Cipto
Mangunkusumo Hospital according to a study from 1987-
1988 is 26%.2 The high mortality rate is very much
influenced by the primary illness or condition resulting in
bleeding.
In Western countries, 50% of upper gastrointestinal
tract bleeding is caused by peptic ulcer.3 In Indonesia,
most bleeding is caused by rupture of esophageal
varices or portal hypertension gastropathy due to liver
cirrhosis.
Non Steroidal Anti-Inflammatory Drugs (NSAIDs)
are now commonly used as a means of treatment. For
example, the use of aspirin has developed immediately,
since aside from acting as an analgetic antipyretic, it also
functions as an anti-platelet aggregation agent. On the
other hand, it could also result in gastrointestinal
complaints of dyspepsia, ulcer, or even severe
complications such as bleeding and perforation.4 In the
United States, the morbidity rate of nausea and dyspep-
sia related to NSAID use is approximately 50-60%, while
3-4% a year suffer from ulceration complicated by
bleeding and perforation.5
Upper gastrointestinal tract abnormalities occur due
to an imbalance of aggressive and defensive factors
according to Shay’s balance theory.6
NSAIDs could incur damage on the gastric mucosa
by way of two mechanisms, the systemic and topical
effects.4,7
In the systemic pathway, it causes damage through
the inhibition of prostaglandin production, particularly
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PGE1, PGE2 and PGI2. Prostaglandin inhibition reduces
mucosal defense against aggressive factors in the
gastric lumen.
NSAIDs also has a topical effect on gastric mucosa,
since it acts as a weak acid, thus becoming non-ionized
lipid soluble in acidic conditions, which allows it to
passively diffuse through the epithelial membrane wall
into the epithelial cell. The neutral pH conditions within
the cell causes drug dissociation into the ionized
non-lipid soluble form, which could no longer freely exit
the cell, thus resulting in “ion trapping”. A high drug
concentration within the cell causes epithelial damage
and facilitates re-diffusion of hydrogen ions.4
NSAID users may complain of dyspepsia, nausea,
vomiting, epigastric pain, or even upper gastrointestinal
tract bleeding. There is no correlation between
symptoms and endoscopic findings.4, 8 An ulcer may still
be detected by endoscopy in the absence of complaints,
while according to data from the Division of
Gastroneterology of the Faculty of Medicine of the
University of Indonesia/Cipto Mangunkusumo Hospital,
30-40% of NSAID users were found without complaints
even though NSAID gastropathy lesions have been
found per endoscopy.7
In the case of NSAID gastropathy, examinations must
be performed to ensure a definite diagnosis.
Termination of NSAID use could prevent further
complications and the mucosal lesion could heal rapidly
using conventional medicine.
Proton pump inhibitors permanently bind to H+, K+
ATPase enzymes or proton-pumps, thus inhibiting acid
secretion. These drugs inhibit 90% of acid production
within 24 hours. A cure rate of over 90% is achieved
after 4 weeks of use for duodenal ulcer and 8 weeks for
gastric ulcer.8, 9
Short-term treatment using proton-pump inhibitors is
safe. Chronic use causes increased serum gastrin levels
associated with gastric enterochromaffin cell hyperplasia
in humans and gastric carcinoid tumor in rats. However,
experience with patients who received PPI treatment for
over 5 years has not demonstrated toxicity.8, 9
A study demonstrated a higher cure rate from all sorts
of ulcer with the administration of proton-pump
inhibitors (72%) compared to H2 antagonists (52%).10
CASE ILLUSTRATION
A male 58 year-old was admitted to the hospital with
a chief complaint of brownish vomiting since the
previous day.
Two weeks prior to admission the patient had
undergone cataract surgery for his left eye, and was
diagnosed with retinal bleeding due to central retinal vein
occlusion, and had received 1 x 10 tablets of prednisone,
2 x 80 mg of aspilets, and 3 x 1 tablet of trental. After
taking the drugs for 10 days, the patient complained of
epigastric pain, heartburn, and nausea.
Since 2 days prior to admission the patient complained
of excreting loose tar black stools 6 times a day
amounting to approximately 2 glasses/day.
Since 1 day prior to admission, the patient got black
bloody vomiting 3 times a day, approximately 2
tablespoons each time, containing food. The patient also
complained of generalized weakness, dizziness and
paleness.
The patient denied any history of fever, transfusion,
intake of rheumatic drugs, painkillers, or traditional herbs.
The patient has also smoked 1 pack of cigarettes per
day for 35 years.
The patient also denied any history of jaundice,
diabetes, heart disease, or previous black vomit and
stools. The patient has a history of hypertension since 2
years prior to admission, taking an uncertain type of drug
and visited the Public Health Center irregularly.
The patient denied of family history of hypertension,
diabetes, and heart disease.
Physical examination during admission revealed the
patient to be moderately ill, fully conscious, weak, with a
blood pressure of 140/90 mmHg, a pulse rate of 100x/
minute, body temperature of 36.70 oC, and a respiratory
rate of 20x/minute. No abnormality was found in the
head. The patient’s conjunctiva were pale, sclera not
jaundiced; ear, nose, and throat normal. The patient’s
jugular venous pressure was 5 – 2 cmH2O. Heart
examination revealed a normal size, normal first and
second heart sounds, without murmur or gallop. Lung
examination revealed a sonor percussion sound,
vesicular breath sound, no rales or wheezing.
Abdominal examination revealed an undistended
abdomen, no epigastric tenderness, no ascites, while the
liver and spleen were not palpable and bowel sounds
normal. The patient’s extremities were warm and not
edematous. There were no liver cirrhosis stigmata such
as spider nevi, ascites, caput medusa, splenomegaly,
collateral vein, and palmar erythema. Rectal touche
revealed normal anal sphincter tone, while the ampulla
was not collapsed, there was no mass, and black feces
were found on the gloves.
Laboratory results were as follows: hemoglobin level
9.7 g/dl, white blood cell count 29.500 / ul, red blood cell
count 3,05 million / ul, hematocryte level 27 vol %,  platelet
Volume 3, Number 2, August 2003 61
Management of Upper Gastrointestinal Bleeding Due to NSAID Gastropathy that is Unresponsive to Ranitidine
count 369,000 / ul. Ureum level was 131 mg/dl, and
creatinine level 1.3 mg/dl. Cito blood sugar was 129 mg/
dl. Sodium level was 130 mEq, potassium level 4.3 mEq.
Urinalysis revealed a urinary pH of 6, with no presence
of protein, glucose, ketone, blood, or bilirubin. Urinary
white blood cell was 2 – 4 /large microscopic view, while
urinary red blood cell was 1 – 2/large microscopic view.
There was no cylinder, crystals, or bacteria in urinary
sedimentation.
Electrocardiography demonstrated sinus rhythm, a
QRS rate of 100 times/minute, normal axis, without right
or left ventricular hypertrophy and no ST changes or T
wave.
Chest x-ray demonstrated a cardiothoracic ratio of
<50%, no infiltrates, and aortal elongation.
The patient was asked to fast, and the following
treatment was procured: a nasogastric tube was inserted,
and spooling with ice water was conducted every six hours
and if two spoolings revealed no blood, the nasogastric
tube may be removed and the patient may gradually
receive gastric diet I. The patient was also scheduled for
enema in the mornings and afternoons, and was given 2 x
1 vial of ranitidine injection and 4 x 1 tablespoon of
sucralfate per nasogastric tube. Transfusion was
administered according to the results of complete blood
check. In addition, 500 cc of NaCI 0.9 % was
administered every 8 hours due to mild hyponatremia.
On the second day of care, the patient still had
approximately 250 cc of black feces, and 100 cc of
bleeding was obtained from the nasogastric tube. There
was a hemoglobin level reduction from 9.7 to 9.1, and
even though the patient had received 200 cc of packed
red cells, the patient received 400 cc more. Liver function
test results and CHE were within normal limits. Protein
evaluation revealed mild hypoalbuminemia, while
cholesterol and  triglyceride levels were within normal
levels.
On the third day, there was still 100 cc of bleeding
from the nasogastric tube and 200 cc of black feces.
On the fifth day, the hemoglobin level had increased
to 12.3 from 8.5 g% after 500 cc of packed red cell
transfusion. Endoscopy revealed ulcerative esophagitis
suspected to be due to gastroesophageal reflux disease,
moderate erosive gastritis, and duodenal ulcer. The
gastroenterology division recommended the
administration of 2 x 10 mg of rabeprazole, 3 x 5 mg of
cisapride, 4 x 1 tablespoons of sucralphate solution, and
the termination of ranitidine. The patient was to undergo
endoscopic evaluation after four weeks of treatment.
On the seventh day, results of hepatitis serology
testing were obtained as follows: negative HbsAg, and
negative anti-HCV IgM. The patient also underwent IgG
anti-Helicobacter pylory testing with negative results.
The opthalmology department was consulted, and
recommended the administration of 3 x 1 tablet of trental
and 4 x 2 drops of cendoxitrol for the left eye.
Funduscopy revealed good condition of the right occular
fundi, while the left is a bit cloudy, with a round papil
with weakly defined borders, as well as bleeding and
fibrosis of the retina. Ureum and creatinine tests were
repeated, demonstrating an improvement where the
ureum level dropped from 131 to 21, and the creatinine
level fell from 1.3 to 0.9, resulting in an increase in
calculated CCT from 54 to 80. Repeat electrolyte also
demonstrated an improvement with a sodium level
increase from 130 to 145.
On the eleventh day, the patient no longer suffered
from black stools and vomiting, and the patient was
released and required to come for regular visits to the
out-patient clinics from the gastroenterology, renal
hypertension, hematology, and opthalmology departments.
The patient was scheduled for a hepatic ultrasound
during his visits.
On the fourth week, an endoscopic examination was
performed as evaluation, revelaing improvements of the
condition of the upper digestive tract and a remaining
scar in the duodenum.
Anatomic pathology evaluation of the tissue obtained
from the antrum of the gastric mucosa concluded that
the patient had a non-active, non-atrophic chronic
gastritis with negative helicobacter pylori.
DISCUSSION
The patient is a fifty-nine year-old male who suf-
fered from hematemesis melena, with a history of ten
days of aspilet and prednisone use due to occlusion of
his left central retinal vein. Literature mentions that
non-steroidal anti-inflammatory drugs (NSAIDs)
including aspirin play an important role in causing
damage of the gastrointestinal mucosa. An endoscopic
survey revealed a high prevalence rate of gastric and
duodenal ulcer in NSAID users of 22% and 3.5%
respectively. A case control study demonstrated that the
risks of ulcer, bleeding, or gastrointestinal perforation
increases 3 to 5 times in NSAID users.8 This patient
took 2 aspilets daily for 10 days, each containing 81 mg
of acetyl salicilate acid.
Risk factors for complications due to NSAID use
include age of over 60 years, history of ulcer, toxic
NSAID use, high doses of NSAID, simultaneous use of
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anticoagulants or steroids, extent of NSAID use, female
sex, rheumatism or cardiovascular disease, helicobacter
pylori infection, smoking, and alcoholism. In this patient,
the risk factors were smoking and simultaneous use of
NSAID and steroid.11
The differential diagnosis for hematemesis melena in
this patient is esophageal varices rupture due to hepatic
cirrhosis. However, no cirrhotic stigmata was clinically
found, and laboratory examination demonstrated a liver
function within normal limits, and negative hepatitis
serology, while hepatic ultrasound did not reveal signs of
liver cirrhosis and endoscopic evaluation did not reveal
esophageal varices. Another possibility is the Mallory
Weiss syndrome, usually preceded by severe vomiting,
causing a tear in the lower esophageal sphincter.2 This
condition was not found in this patient.
Endoscopic findings of the distal esophagus
demonstrated hyperemic ulceration due to ulcerative
esophagitis. Such destruction may be due to the
consumption of certain drugs, one of which is NSAID
(the condition is called pill esophagitis). Such esophageal
abnormality may cause hematemesis even though the
bleeding that ensues is rarely massive.12
The patient took a low dose of aspirin for ten days
before suffering from upper gastrointestinal bleeding
preceded by complaints of dyspepsia and heartburn.
Literature states that within few minutes, NSAID
consumption is followed by ultra-structural damage of
surface epithelial cells of the gaster. Endoscopy would
reveal bleeding and erosion of the gastroduodenal
epithelium for several hours following NSAID
consumption. Most complications due to NSAID use
occur within one month of drug consumption.4
Histopathological examination from tissue taken from
the antrum during endoscopy revealed chronic non-
active non-atrophic gastritis, which resembles reactive
gastritis due to bile reflux. This is in line with literature
that mentions that findings of NSAID gastropathy
resemble bile reflux gastritis, where there is foveolate
hyperplasia, vascular extasia, and increased smooth
muscle cell fibers.8
Histopathological and serological evaluation for
helicobacter pylori was performed to determine risk
factors for NSAID complications and to determine the
etiology of duodenal ulcer in this patient. The
examinations did not reveal helicobacter pylori infection.
Thus, the patient did not receive eradication treatment.
The first form of treatment in this patient is the
management of hematemesis melena while maintaining
adequate circulation. A nasogastric tube was inserted to
detect upper gastrointestinal bleeding, monitor activity
or the severity of bleeding, administer medications,
perform gastric lavage, and predict prognosis. An
intravenous line was also inserted for preparation for
transfusion as well as fluid resuscitation using
crystalloid in case of shock.
In addition, drugs were administered to deal with
gastric abnormality due to reduced prostaglandin
production as well as to reduce gastric acidity, which
could aggravate damage of the gastric mucosa.
Sucralphate was also administered. A study
demonstrates that sucralphate is able to reduce damage
of the digestive tract mucosa due to NSAIDs.
However, a larger study by Agrawal et al demonstrated
no significant benefit in the use of sucralphate for the
prevention of ulcer in NSAID use.4 Nevertheless, in
cases like these where gastrointestinal tract bleeding has
occured, sucralphate may be administered to increase
defence of the upper gastrointestinal tract.2
The patient initially receives ranitidine, but on the fifth
day, due to continued bleeding treatment was switched
to proton-pump inhibitor. A study demonstrated that
proton-pump inhibitors produced a higher average
healing rate from various types of ulcers (72%)
compared to H2 antagonists (52%).10
The patient also received a pro-kinetic drug, which is
good for patients with esophageal abnormality.
Endoscopy revealed ulcerative esophagitis, though to be
due to NSAID consumption aggravated by esophageal
reflux. A study demonstrated that the use of prokinetic
agents produced better results compared to placebo in
treating esophageal reflux.12
H. pylori eradication was not performed in this
patient, since there was no proof of H. pylori infection in
serological and histopathological examination. In
addition, other literature mention that the benefits of
H. pylori eradication in NSAID gastropathy is still
unclear.13
After 4 weeks of treatment with sucralphate,
prokinetic agents, and PPI, the patient was re-evaluated
by endoscopy, revealing improvements in the upper
gastrointestinal tract.
This case was presented to remind us on the need to
protect the digestive tract when administering NSAID
and the presence of risk factors such as old age,
combination with corticosteroids, etc, to avoid side
effects that could produce dangerous complications such
as gastrointestinal bleeding due to NSAID gastropathy.
Volume 3, Number 2, August 2003 63
Management of Upper Gastrointestinal Bleeding Due to NSAID Gastropathy that is Unresponsive to Ranitidine
REFERENCES
1. Djojodiningrat, Hardjodisastro D. Hematemesis Melena. In:
Simadibrata M, Setiati S, Alwi I, Maryantoro, Gani RA,
Mansjoer A, editors. Pedoman diagnosis dan terapi di bidang
ilmu penyakit dalam. Jakarta : Pusat Informasi dan Penerbitan
Bagian IPD FKUI; 1999.p. 20–4
2. Djojodiningrat, D. Hematemesis Melena. In: Subekti I, Lydia A,
Rumende CM, Syam AF, Mansjoer A, Suprohaita, editors.
Prosiding simposium : Penatalaksanaan Kegawatdaruratan di
Bidang Ilmu Penyakit Dalam. Jakarta: Pusat Informasi dan
Penerbitan Bagian IPD FKUI; 2001.p. 111–6
3. Laine L. Gastrointestinal Bleeding. In: Braunwald E, Fauci AS,
Kasper DL, Hauser SL, editors. Int Harrison’s Principles of
Internal Medicine. 15th ed. New York: Mc.Graw-Hill; 2001.p.
252–3
4. Wolfe MM, Lichtenstein DR, Singh G. Gasrtointestinal
toxicity of nonsteroidal antiinflamatory drugs. N. Engl. J. Med
1999 ; 340: 1888–99
5. Valle, JD. Peptic Ulcer Disease and Related Disorders. In:
Braunwald E, Fauci AS, Kasper DL, Hauser SL, editors. Int
Harrison’s Principles of Internal Medicine. 15th ed. New York :
Mc.Graw-Hill; 2001.p. 1649–65
6. Manan C. Obat antiinflamasi nonsteroid dan dispepsia:
Pencegahan dan pengobatannya. In: Setiati S, Sudoyo AW, Alwi
I, Bawazier LA. Soejono CZ, Lydia A, et al, editors. Naskah
Lengkap Pertemuan Ilmiah Tahunan  Ilmu Penyakit Dalam 2000.
Jakarta: Pusat Informasi dan Penerbitan Bagian IPD FKUI;
2000.p. 75-81
7. Djojodiningrat D. Gastropati OAINS: Tatalaksana Praktis
Pencegahan dan Pengobatan. In: Setiati S, Bawazier LA,
Atmakusuma D, Kasjmir YI, Syam AF, Gustaviano R, editors.
Prosiding Simposium : Current Diagnosis and Treatment In In-
ternal Medicine 2000. Jakarta  : Pusat Informasi dan Penerbitan
Bagian IPD FKUI; 2000.p. 81-7
8. Massie B, Alimentary Tract. In: Tierney LM, Mc Phee SJ,
Papadakis MA, A Lange Medical Book, Current Medical Diag-
nosis and Treatment 2001, 40th Ed. San Francisco: McGraw-
Hill; 2001.p. 573-611
9. Informatorium Obat Nasional Indonesia 2000, Departemen
Kesehatan Republik Indonesia, Direktorat Jenderal Pengawasan
Obat dan Makanan, 2000: 21
10. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, Van
Rensburg CJ, et al. A Comparison of Omeprazole with Ranitidine
for Ulcers Assosiated with Nonsteroidal Antiinflamatory drugs.
N. Engl. J. Med. 1998 ; 338: 719–26
11. Seager JM, Hawkey CJ. Indigestion Nonsteroidal anti-
inflamatory Drugs, BMJ 2001; 323: 1236–9
12. Goyal RK. Disease of The Esophagus. In Braunwald E, Fauci
AS, Kasper DL, Hauser SL, Eds Int Harrison’s Principles of
Internal Medicine. 15th ed. New York : Mc.Graw-Hill; 2001.p.
1645–9
13. Chan FKL, Chungs, Suen BY, Lee YT, Leung WK, Leung VKS,
et al. Preventing Recurrent Upper gastrointestinal Bleeding in
Patients with Helicobacter pylori Infection Who Are Taking
Low Dose Aspirin or Naproxen. N. Engl. J. Med. 2001; 344:
967–73
